Reliability of the Modified TICI Score among Endovascular Neurosurgeons

References

1. 1.↵
   1. Goyal M,
   2. Menon BK,
   3. van Zwam WH, et al

   ; HERMES Collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

   CrossRefPubMed
2. 2.↵
   1. Nogueira RG,
   2. Jadhav AP,
   3. Haussen DC, et al

   ; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
3. 3.↵
   1. Albers GW,
   2. Marks MP,
   3. Kemp S

   , et al. DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–18 doi:10.1056/NEJMoa1713973 pmid:29364767

   CrossRefPubMed
4. 4.↵
   1. Berkhemer OA,
   2. Fransen PS,
   3. Beumer D, et al

   ; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20 doi:10.1056/NEJMoa1411587 pmid:25517348

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Goyal M,
   2. Demchuk AM,
   3. Menon BK, et al

   ; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30 doi:10.1056/NEJMoa1414905 pmid:25671798

   CrossRefPubMed
6. 6.↵
   1. Campbell BC,
   2. Mitchell PJ,
   3. Kleinig TJ, et al

   ; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009–18 doi:10.1056/NEJMoa1414792 pmid:25671797

   CrossRefPubMed
7. 7.↵
   1. Saver JL,
   2. Goyal M,
   3. Bonafe A, et al

   ; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372:2285–95 doi:10.1056/NEJMoa1415061 pmid:25882376

   CrossRefPubMed
8. 8.↵
   1. Jovin TG,
   2. Chamorro A,
   3. Cobo E, et al

   ; REVASCAT Trial investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015;372:2296–2306 doi:10.1056/NEJMoa1503780 pmid:25882510

   CrossRefPubMed
9. 9.↵
   1. Bracard S,
   2. Ducrocq X,
   3. Mas JL, et al

   ; THRACE Investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016;15:1138–47 doi:10.1016/S1474-4422(16)30177-6 pmid:27567239

   CrossRefPubMed
10. 10.↵
    1. Tomsick T,
    2. Broderick J,
    3. Carrozella J, et al

    ; Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582–87 doi:10.3174/ajnr.A0843 pmid:18337393

    Abstract/FREE Full Text
11. 11.↵
    1. Fleiss JL,
    2. Levin B,
    3. Paik MC

    . Statistical Methods for Rates and Proportions. Wiley; 2003
12. 12.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74 pmid:843571

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Mori E,
    2. Yoneda Y,
    3. Tabuchi M, et al

    . Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976–82 doi:10.1212/wnl.42.5.976 pmid:1579252

    Abstract/FREE Full Text
14. 14.↵
    1. Higashida RT,
    2. Furlan AJ,
    3. Roberts H, et al

    ; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–37 doi:10.1161/01.STR.0000082721.62796.09 pmid:12869717

    Abstract/FREE Full Text
15. 15.↵
    1. Khatri P,
    2. Neff J,
    3. Broderick JP, et al

    ; IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400–03 doi:10.1161/01.STR.0000185698.45720.58 pmid:16224088

    Abstract/FREE Full Text
16. 16.↵
    1. Noser EA,
    2. Shaltoni HM,
    3. Hall CE, et al

    . Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke 2005;36:292–96 doi:10.1161/01.STR.0000152331.93770.18 pmid:15625300

    Abstract/FREE Full Text
17. 17.↵
    1. Demchuk AM,
    2. Burgin WS,
    3. Christou I, et al

    . Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001;32:89–93 doi:10.1161/01.str.32.1.89 pmid:11136920

    Abstract/FREE Full Text
18. 18.↵
    1. Qureshi AI

    . New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50:1405–14; discussion 1414–15 pmid:12015866

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Bar M,
    2. Mikulik R,
    3. Jonszta T, et al

    . Diagnosis of recanalization of the intracranial artery has poor inter-rater reliability. AJNR Am J Neuroradiol 2012;33:972–74 doi:10.3174/ajnr.A2896 pmid:22241381

    Abstract/FREE Full Text
20. 20.↵
    1. Gaha M,
    2. Roy C,
    3. Estrade L, et al

    . Inter- and intraobserver agreement in scoring angiographic results of intra-arterial stroke therapy. AJNR Am J Neuroradiol 2014;35:1163–69 doi:10.3174/ajnr.A3828 pmid:24481332

    Abstract/FREE Full Text
21. 21.↵
    1. Suh SH,
    2. Cloft HJ,
    3. Fugate JE, et al

    . Clarifying differences among thrombolysis in cerebral infarction scale variants: is the artery half open or half closed? Stroke 2013;44:1166–68 doi:10.1161/STROKEAHA.111.000399 pmid:23412375

    Abstract/FREE Full Text
22. 22.↵
    1. Volny O,
    2. Cimflova P,
    3. Szeder V

    . Inter-rater reliability for thrombolysis in cerebral infarction with TICI 2c category. J Stroke Cerebrovasc Dis 2017;26:992–94 doi:10.1016/j.jstrokecerebrovasdis.2016.11.008 pmid:27919793

    CrossRefPubMed
23. 23.↵
    1. Fahed R,
    2. Ben Maacha M,
    3. Ducroux C, et al

    ; ASTER Trial Investigators. Agreement between core laboratory and study investigators for imaging scores in a thrombectomy trial. J Neurointerv Surg 2018;10:e30 doi:10.1136/neurintsurg-2018-013867 pmid:29760012

    Abstract/FREE Full Text
24. 24.↵
    1. Saver JL,
    2. Jahan R,
    3. Levy EI, et al

    ; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241–49 doi:10.1016/S0140-6736(12)61384-1 pmid:22932715

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Nogueira RG,
    2. Lutsep HL,
    3. Gupta R, et al

    ; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231–40 doi:10.1016/S0140-6736(12)61299-9 pmid:22932714

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Zhang G,
    2. Treurniet KM,
    3. Jansen IG, et al

    ; for the MR CLEAN Registry Investigators. Operator versus core lab adjudication of reperfusion after endovascular treatment of acute ischemic stroke. Stroke 2018;49:2376–82 doi:10.1161/STROKEAHA.118.022031 pmid:30355107

    CrossRefPubMed